Change search
ReferencesLink to record
Permanent link

Direct link
Improving anti-drug antibody assay performance in Gyrolab for therapeutic recombinant antibody Infliximab
Linköping University, Department of Clinical and Experimental Medicine. Linköping University, Faculty of Health Sciences.
2014 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Monoclonal antibodies can be used as targeting therapies for several diseases. One major concern when using these therapies is anti-drug antibodies which may hamper the drugs efficiency. Gyrolab is an automated platform which can be used to develop bridging immunoassays where the anti-drug antibodies affinity towards the monoclonal antibody is utilized. Anti-drug antibody immunoassay development on Gyrolab is limited mainly by three factors which may inappropriately affect signal intensity levels. In this project different variants of bridging immunoassays based on drug Fab fragments have been developed for monoclonal antibody Infliximab, with the purpose to illustrate the effects of these three factors.

Findings indicate that an assay based completely on drug Fab fragments is more sensitive compared to an assay based on intact drug since less affected by unspecific interactions between drug reagents and complex formations. Surprisingly findings also indicate that an assay based completely on drug Fab fragments is affected by human anti-hinge antibodies which decrease assay sensitivity. The most optimal assay variant is based on the combination between intact capture drug and Fab fragment as detection. This variant is insensitive to false positive reactions caused by Rheumatoid factor and human anti-hinge antibodies, less prone to form unspecific interactions between drug reagents and complex formations in the presence of anti-drug antibodies. The optimal assay variant also demonstrates best drug tolerance in combination with acid dissociation.

Place, publisher, year, edition, pages
2014. , 61 p.
National Category
Bioengineering Equipment
URN: urn:nbn:se:liu:diva-111527ISRN: LiU-IKE-EX—14/05--SEOAI: diva2:757338
Subject / course
2014-06-02, Hagdahlsalen, Campus US, Linköping, 14:00 (Swedish)
Available from: 2014-10-22 Created: 2014-10-21 Last updated: 2014-10-22Bibliographically approved

Open Access in DiVA

Master thesis Cecilia Bill(2231 kB)383 downloads
File information
File name FULLTEXT01.pdfFile size 2231 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Search in DiVA

By author/editor
Cecilia, Bill
By organisation
Department of Clinical and Experimental MedicineFaculty of Health Sciences
Bioengineering Equipment

Search outside of DiVA

GoogleGoogle Scholar
Total: 383 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 750 hits
ReferencesLink to record
Permanent link

Direct link